Clinical trial
Hydroxychloroquine Treatment During Pregnancy is Associated With Lower Risk of Preeclampsia in Patients With Recurrent Spontaneous Abortion of Unknown Aetiology
NCT06020378 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxychloroquine Treatment During Pregnancy is Associated With Lower Risk of Preeclampsia in Patients With Recurrent Spontaneous Abortion of Unknown Aetiology
- Lead sponsor
- RenJi Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 1, 2024
- Completion date
- December 1, 2026
- Enrollment
- 462 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.